Mechanisms of leukemia translocations

Current Opinion in Hematology

Volumn 15, Issue 4, 2008, Pages 338-345

  Nickoloff, Jac A ^a   De Haro, Leyma P ^a   Wray, Justin ^a   Hromas, Robert ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Chromosomal translocations; DNA double strand break repair; Nonhomologous endjoining; V(D)J recombination

Indexed keywords

ANTHRACYCLINE; CAMPTOTHECIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DOUBLE STRANDED DNA; ETOPOSIDE; HYDROXYUREA;

CANCER CHEMOTHERAPY; CELL CYCLE; CHROMOSOME TRANSLOCATION; DNA REPAIR; DNA SEQUENCE; DOUBLE STRANDED DNA BREAK; GENE NUMBER; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; LEUKEMOGENESIS; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REVIEW; ARTICLE; GENE TRANSLOCATION; GENETICS;

CELL CYCLE; DNA REPAIR; HUMANS; LEUKEMIA; TRANSLOCATION, GENETIC;

EID: 47149087178     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328302f711     Document Type: Review

References (71)

1. Kelly LM, Gilliland DG. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002; 3:179-198.
2. Murnane JP. Telomeres and chromosome instability. DNA Repair 2006; 5:1082-1092.
3. Vukovic B, Beheshti B, Park P, et al. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer. Cytogenet Genome Res 2007; 116:1-11.
4. Richardson C, Moynahan ME, Jasin M. Double-strand break repair by inter-chromosomal recombination: suppression of chromosomal translocations. Genes Dev 1998; 12:3831-3842.
5. Richardson C, Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 2000; 405:697-700.
6. Cremer T, Cremer M, Dietzel S, et al. Chromosome territories-a functional nuclear landscape. Curr Opin Cell Biol 2006; 18:307-316.
7. Gue M, Sun JS, Boudier T. Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited. BMC Cancer 2006; 6:20.
8. de Jager M, van Noort J, van Gent DC, et al. Human Rad50/Mre11 is a flexible complex that can tether DNA ends. Mol Cell 2001; 8:1129-1135.
9. Weinstock DM, Brunet E, Jasin M. Formation of NHEJ-derived reciprocal chromosomal translocations does not require Ku70. Nat Cell Biol 2007; 9:978-981.
10. Soutoglou E, Dorn JF, Sengupta K, et al. Positional stability of single double-strand breaks in mammalian cells. Nat Cell Biol 2007; 9:675-682.
11. Andreassen PR, Ho GP, D'Andrea AD. DNA damage responses and their many interactions with the replication fork. Carcinogenesis 2006; 27:883-892.
12. Shen Z, Nickoloff JA. Mammalian homologous recombination repair and cancer intervention. In: Wei Q, Li L, Chen DJ, editors. DNA repair, genetic instability, and cancer. Singapore: World Scientific Publishing Co.; 2007 pp. 119-156.
13. Damelin M, Bestor TH. The decatenation checkpoint. Br J Cancer 2007; 96:201-205.
14. Lieber MR, Yu K, Raghavan SC. Roles of nonhomologous DNA end joining, V(D)J recombination, and class switch recombination in chromosomal translocations. DNA Repair 2006; 5:1234-1245.
15. Yan CT, Boboila C, Souza EK, et al. IgH class switching and translocations use a robust nonclassical end-joining pathway. Nature 2007; 449:478-482.
16. Keeney S, Neale MJ. Initiation of meiotic recombination by formation of DNA double-strand breaks: mechanism and regulation. Biochem Soc Trans 2006; 34 (Pt 4):523-525.
17. Bandyopadhyay R, Heller A, Knox-DuBois C, et al. Parental origin and timing of de novo Robertsonian translocation formation. Am J Hum Genet 2002; 71:1456-1462.
18. Huang CH, Treat J. New advances in lung cancer chemotherapy: topotecan and the role of topoisomerase I inhibitors. Oncology 2001; 61 (Suppl 1): 14-24.
19. Kurose A, Tanaka T, Huang X, et al. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis. Cytometry A 2005; 68:1-9.
20. Zhang Y, Rowley JD. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair 2006; 5:1282-1297.
21. Aplan PD. Causes of oncogenic chromosomal translocation. Trends Genet 2006; 22:46-55.
22. Felix CA, Kolaris CP, Osheroff N. Topoisomerase II and the etiology of chromosomal translocations. DNA Repair 2006; 5:1093-1108.
23. Kim H, Liu X, Kobayashi T, et al. Reversible cigarette smoke extract-induced DNA damage in human lung fibroblasts. Am J Respir Cell Mol Biol 2004; 31:483-490.
24. Collier AC, Dandge SD, Woodrow JE, Pritsos CA. Differences in DNA-damage in nonsmoking men and women exposed to environmental tobacco smoke (ETS). Toxicol Lett 2005; 158:10-19.
25. Weinstock DM, Richardson CA, Elliott B, Jasin M. Modeling oncogenic translocations: distinct roles for double-strand break repair pathways in translocation formation in mammalian cells. DNA Repair 2006; 5:1065-1074.
26. Tutt A, Bertwistle D, Valentine J, et al. Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J 2001; 20:4704-4716.
27. Lobrich M, Jeggo PA. Harmonising the response to DSBs: a new string in the ATM bow. DNA Repair 2005; 4:749-759.
28. Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 2006; 24:541-570.
29. Ahnesorg P, Smith P, Jackson SP. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 2006; 124:301-313.
30. BuckD, Malivert L, deChasseval R, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 2006; 124:287-299.
31. Lee SH, Oshige M, Durant ST, et al. The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair. Proc Natl Acad Sci USA 2005; 102:18075-18080.
32. Roman Y, Oshige M, Lee YJ, et al. Biochemical characterization of a SET and transposase fusion protein. Metnase: its DNA binding and DNA cleavage activity. Biochemistry 2007; 46:11369-11376.
33. Wang H, Rosidi B, Perrault R, et al. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res 2005; 65:4020-4030.
34. Perrault R, Wang H, Wang M, et al. Backup pathways of NHEJ are suppressed by DNA-PK. J Cell Biochem 2004; 92:781-794.
35. Wang M, Wu W, Wu W, et al. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res 2006; 34:6170-6182.
36. Povirk LF. Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks. DNA Repair 2006; 5:1199-1212.
37. Umezu K, Nakayama K, Nakayama H. Escherichia coli RecQ protein is a DNA helicase. Proc Natl Acad Sci USA 1990; 87:5363-5367.
38. Wang W, Seki M, Otsuki M, et al. The absence of a functional relationship between ATM and BLM, the components of BASC, in DT40 cells. Biochim Biophys Acta 2004; 1688:137-144.
39. Wang W, Seki M, Narita Y, et al. Possible association of BLM in decreasing DNA double strand breaks during DNA replication. EMBO J 2000; 19:3428-3435.
40. BachratiCZ, BortsRH,Hickson ID. Mobile D-loopsarea preferred substrate for the Bloom's syndrome helicase. Nucleic Acids Res 2006; 34:2269-2279.
41. Davies SL, North PS, Hickson ID. Role for BLM in replication-fork restart and uppression of origin firing after replicative stress. Nat Struct Mol Biol 2007; 14:677-679.
42. Shen JC, Gray MD,OshimaJ, et al. Werner syndrome protein. I. DNA helicase and DNA exonuclease reside on the same polypeptide. J Biol Chem 1998; 273:34139-34144.
43. Huang S, Li B, Gray MD, et al. The premature ageing syndrome protein, WRN, is a 3′→5′ exonuclease. Nature Genet 1998; 20:114-116.
44. Huang S, Beresten S, Li B, et al. Characterization of the human and mouse WRN 3′→5′ exonuclease. Nucleic Acids Res 2000; 28:2396-2405.
45. Kamath-Loeb AS, Shen JC, Loeb LA, Fry M. Werner syndrome protein. II. Characterization of the integral 3′→5′ DNA exonuclease. J Biol Chem 1998; 273:34145-34150.
46. Suzuki N, Shimamoto A, Imamura O, et al. DNA helicase activity in Werner's syndrome gene product synthesized in a baculovirus system. Nucleic Acids Res 1997; 25:2973-2978.
47. Constantinou A, Tarsounas M, Karow JK, et al. Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep 2000; 1:80-84.
48. Hanada K, Hickson ID. Molecular genetics of RecQ helicase disorders. Cell Mol Life Sci 2007; 64:2306-2322.
49. Lee JH, Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 2007; 26:7741-7748.
50. BakkenistCJ,Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499-506.
51. Demuth I, Digweed M. The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome. Oncogene 2007; 26:7792-7798.
52. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 2007; 8:735-748.
53. Dokal I. Fanconi's anaemia and related bone marrow failure syndromes. Br Med Bull 2006; 77-78:37-53.
54. Franco S, Alt FW, Manis JP. Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations. DNA Repair 2006; 5:1030-1041.
55. Ferguson DO, Alt FW. DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene 2001; 20:5572-5579.
56. Mills KD, Ferguson DO, Alt FW. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev 2003; 194:77-95.
57. Libura J, Slater DJ, Felix CA, Richardson C. Therapy-related acute myeloid leukemia-like MLL rearrangements are inducedby etoposideinprimary human CD34+ cells and remain stable after clonal expansion. Blood 2005; 105: 2124-2131.
58. Felix CA. Leukemias related to treatment with DNA topoisomerase II inhibitors. Medical and pediatric oncology 2001; 36:525-535.
59. Larson RA, Le Beau MM, Ratain MJ, Rowley JD. Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia. Blood 1992; 79:1892-1893.
60. Pedersen-Bjergaard J, Philip P. Two different classes of therapy-related and de-novo acute myeloid leukemia? Cancer Genet Cytogenet 1991; 55:119- 124.
61. Izumi T, Ohtsuki T, Ohya K, et al. Therapy-related leukemia with a novel 21q22 rearrangement. Cancer Genet Cytogenet 1996; 90:45-48.
62. Slovak ML, Bedell V, Popplewell L, et al. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop. Genes Chromosomes Cancer 2002; 33:379- 394.
63. Strissel PL, Strick R, Rowley JD, Zeleznik-Le NJ. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood 1998; 92:3793-3803.
64. Domer PH, Head DR, Renganathan N, et al. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11). Leukemia 1995; 9:1305-1312.
65. Stanulla M, Schunemann HJ, Thandla S, et al. Pseudo-rearrangement of the MLL gene at chromosome 11q23: a cautionary note on genotype analysis of leukaemia patients. Mol Pathol 1998; 51:85-89.
66. Aplan PD. Chromosomal translocations involving the MLL gene: molecular mechanisms. DNA Repair 2006; 5:1265-1272.
67. Strout MP, Marcucci G, Bloomfield CD, Caligiuri MA. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci U S A 1998; 95:2390-2395.
68. Elliott B, Richardson C, Jasin M. Chromosomal translocation mechanisms at intronic alu elements in mammalian cells. Mol Cell 2005; 17:885-894.
69. Lewis SM, Agard E, Suh S, Czyzyk L. Cryptic signals and the fidelity of V(D)J joining. Mol Cell Biol 1997; 17:3125-3136.
70. Raghavan SC, Kirsch IR, Lieber MR. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints. J Biol Chem 2001; 276:29126-29133.
71. Unniraman S, Schatz DG. AID and Igh switch region-Myc chromosomal translocations. DNA Repair 2006; 5:1259-1264.